Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.


NDAQ:NVCN - Post by User

<< Previous
Bullboard Posts
Next >>
Post by onions7777on Aug 07, 2018 8:43am
120 Views
Post# 28419937

3 News releases+ 30m Vol = only .005 gain?!?

3 News releases+ 30m Vol = only .005 gain?!?It's a good flip, but it won't hold. Especially after Q2 report. How much money do you think a company with no products makes? Burn Rate requiring off the shelf financing to continue? I wouldn't be surprised if RS is announced on conference call. L2 shows most buy orders in at .04CAD (6539000 shares) If history teaches us anything about this, it's that the news releases were used to drive up the price, so the dismal Q2 report won't crash SP much lower than 10 day average. Plan didn't work this time. Even the movement on premarket is the same guys buying just enough to move the bid up then they sell.
<< Previous
Bullboard Posts
Next >>